To describe the predictive value of information on previous benign biopsy for the outcome of MRI-targeted biopsies.
An exploratory analysis was conducted using data from a prospective, multicenter, paired diagnostic study of 532 men undergoing diagnostics for prostate cancer during 2016-2017.